Craft

Galderma

Revenue

$3.8 B

FY, 2022

Galderma Summary

Company Summary

Overview
Galderma is a pharmaceutical company specializing in dermatological treatments and skincare products. It provides a range of products used to treat acne, rosacea, psoriasis, and other steroid-responsive dermatoses (SRD), onychomycosis (fungal nail infections), pigmentary disorders, skin cancer, and skin senescence. The company offers its products under brand names such as Aklief, Epiduo, Epidio Forte, Differin, Soolantra, Mirvaso, Oracea, Metvix, Restylane, Restylane Skinboosters, Azzalure, Dysport, and Sculptra.
Type
Subsidiary
Status
Active
Founded
1981
HQ
Zug, CH | view all locations
Website
https://www.galderma.com
Cybersecurity rating
Sectors

Key People

  • Flemming Ornskov

    Flemming Ornskov, Chief Executive Officer

  • Allison Pinkham

    Allison Pinkham, Chief Human Resources Officer

    • Thomas Dittrich

      Thomas Dittrich, Chief Financial Officer

    • Nakisa Serry

      Nakisa Serry, General Counsel, Chief Compliance Officer

    Operating MetricsView all

    Annual Production Capacity, units

    280M
    99999900.0%

    FY, 2022

    Countries

    90

    FY, 2022

    Manufacturing Sites

    4

    FY, 2022

    LocationsView all

    26 locations detected

    • Zug, ZG HQ

      Switzerland

      Zählerweg 10

    • Fort Worth, TX

      United States

      14501 N Fwy

    • Buenos Aires, Provincia de Buenos Aires

      Argentina

      Av. del Libertador 1000

    • Sydney, NSW

      Australia

      Level 18/1 Denison St

    • Wien, Wien

      Austria

      Gertrude-Fröhlich-Sandner-Straße 3

    • Baie-d'Urfé, QC

      Canada

      19400 Route Transcanadienne

    and 20 others

    Galderma Financials

    Summary Financials

    Revenue (FY, 2022)
    $3.8B

    Footer menu